SK Life Science, Inc., the U.S. subsidiary of SK Biopharmaceuticals, is an innovative global pharmaceutical company focused on the research, development and treatment of central nervous system (CNS) disorders. The company has a pipeline of eight compounds in development for CNS disorders. For more information about SK life science, please visit us at, sklifescienceinc.com .
In 2020, SK life science received FDA approval for XCOPRI® (cenobamate tablets) CV.
For more information about XCOPRI®, please visit xcopri.com .
CONNECT WITH SK LIFE SCIENCE, INC.
Latest Sponsored Posts
Pro Golfer Kenzie O’Connell On Taking Control of Her Epilepsy and Fighting for Zero Seizures
STEPS Toward Zero champion, Kenzie O’Connell, and epilepsy advocate, Landis Wiedner, share about their experiences living with and managing epilepsy
Epilepsy Blog Relay: Racing Toward Seizure Freedom
Former TV news anchor and marathon runner Sarah Carlson shares about her journey with epilepsy as she races toward seizure freedom.
Fighting for the Possibility of Zero Seizures
XCOPRI® patient Koral knows the challenges of living with epilepsy and the significance of potentially living with zero seizures.